A Home-based Exercise and Physical Activity Intervention After Liver Transplantation: Impact of Exercise Intensity
Conditions: Liver Transplantation; Physical Fitness; Cardiovascular Health Interventions: Other: Physical activity; Other: Sham intervention Sponsors: Universitaire Ziekenhuizen KU Leuven; KU Leuven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
The AI-CAC Model for Subclinical Atherosclerosis Detection on Chest X-ray
Conditions: Cardiovascular Diseases; Atherosclerosis; Coronary Artery Calcification Interventions: Diagnostic Test: AI-CAC score Sponsors: Azienda Ospedaliera Citt à della Salute e della Scienza di Torino; Compagnia di San Paolo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
Conditions: Hypertension; Diabetes Mellitus Type 2; Cardiovascular Diseases Interventions: Other: Team-based care; Procedure: Risk-stratified care pathway; Behavioral: Strengthened health education; Other: Financial incentives for integration of care; Other: Supporting health information system Sponsors: Peking University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
Conditions: Diabetes Type 2 Interventions: Drug: Semaglutide, 1.0 mg/mL; Drug: Dipeptidyl Peptidase 4 inhibitor Sponsors: Attikon Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Argentine Registry of Lp(a)
Conditions: Lp(A); Hypercholesterolemia; Cardiovascular Diseases; Diabete Type 2; Hypertension Sponsors: School of Medicine. National University of Cuyo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Global Paradise System US Post Approval Study
Conditions: Hypertension; Cardiovascular Diseases; Vascular Diseases Interventions: Device: Paradise Ultrasound Renal Denervation Treatment Sponsors: ReCor Medical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
A Study Assessing Repatha ® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
Conditions: Major Cardiovascular Event; Established Atherosclerotic Cardiovascular Disease Sponsors: Amgen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Intervention and Effect of Sleep Pattern on Cardio-cerebrovascular Disease
Conditions: Cardiovascular Diseases; Non-Communicable Chronic Diseases Interventions: Behavioral: sleep education, behavioral education Sponsors: RenJi Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Multimarker Approach in Acute Chest Pain
Conditions: Cardiovascular Disease Other Interventions: Diagnostic Test: Biochemical marker assays Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Noise, Oxidative Stress and Cardiovascular System
Conditions: Noise; Adverse Effect; Noise Exposure Interventions: Other: Exposure to loud pre-recorded road traffic noise Sponsors: University of Belgrade Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Conditions: Atherosclerotic Cardiovascular Disease (ASCVD); Elevated Lp(a) Interventions: Drug: Lepodisiran Sodium; Drug: Placebo Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Factors Associated With Posttransplant Cardiac Outcomes
Conditions: Cardiovascular Diseases; Liver Transplantation Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)
Conditions: Diabetes Mellitus, Type 1; Cardiovascular Diseases Interventions: Other: Standard of care plus additional examinations Sponsors: Centro Cardiologico Monzino Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
CARDIOneuroablation for Bradyarrhythmia: a Multicentre cOntrOlled Interventional randomiSed Trial
Conditions: Bradycardia; Syncope; Sick Sinus Syndrome Interventions: Procedure: Ganglionated plexi ablation; Diagnostic Test: Electrophysiological study Sponsors: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health; Meshalkin National Medical Research Center, Ministry of Health of Russian Federation; The Federal Centre of Cardiovascular Surgery, Russia; Clinical City Hospital named after I.V. Davydovsky of Moscow Department of Healthcare; City Clinical Hospital No.52 of Moscow Healthcare Department; National Medical Research Center for Therapy and Prevent...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
Conditions: Chronic Kidney Diseases; Hypertension; Cardiovascular Diseases Interventions: Dietary Supplement: Propolis + Royal Jelly; Dietary Supplement: Royal Jelly; Dietary Supplement: Placebo Sponsors: Universidade Federal Fluminense; Conselho Nacional de Desenvolvimento Cient ífico e Tecnológico; Rio de Janeiro State Research Supporting Foundation (FAPERJ); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
